Recent work (Zhu et al., 2019) on head and neck cancer radiomics has shown that radiomic features can be used to predict HPV infection as well as TP53 mutation status, which suggests that radiomic features can serve as relevant biomarkers for genomic alterations in the tumor. The gene discussed is TP53; the disease is neoplasm.